Recent Insider Transactions - Apellis Pharmaceuticals (NASDAQ: APLS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

06/16/2025

Sell

$18.77

5,000

$94K

133,730

NASDAQ APLS Apellis Pharmaceuticals

Boucher Kelley / officer: Chief People Officer

06/09/2025

Buy

$19.39

67,396

$1.307M

67,396

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

06/09/2025

Buy

$19.39

82,500

$1.600M

82,500

NASDAQ APLS Apellis Pharmaceuticals

Nicholson Nur / officer: Chief Technical Officer

06/09/2025

Buy

$19.39

82,500

$1.600M

82,500

NASDAQ APLS Apellis Pharmaceuticals

Francois Cedric / director, officer: Chief Executive Officer

06/09/2025

Buy

$19.39

287,500

$5.575M

287,500

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

06/09/2025

Buy

$19.39

82,500

$1.600M

82,500

NASDAQ APLS Apellis Pharmaceuticals

Deschatelets Pascal / officer: Chief Scientific Officer

06/09/2025

Buy

$19.39

82,500

$1.600M

82,500

NASDAQ APLS Apellis Pharmaceuticals

Baumal Caroline / officer: Chief Medical Officer

06/09/2025

Buy

$19.39

82,500

$1.600M

82,500

NASDAQ APLS Apellis Pharmaceuticals

Chopas James George / officer: VP/Chief Accounting Officer

06/09/2025

Buy

$19.39

11,250

$218K

11,250

NASDAQ APLS Apellis Pharmaceuticals

DeLong Mark Jeffrey / officer: Chief Business & Strat Officer

06/09/2025

Buy

$19.39

82,500

$1.600M

82,500

NASDAQ APLS Apellis Pharmaceuticals

Boucher Kelley / officer: Chief People Officer

05/28/2025

Buy

$16.80

32,976

$554K

32,976

NASDAQ APLS Apellis Pharmaceuticals

Deschatelets Pascal / officer: Chief Scientific Officer

05/21/2025

Buy

$3.76

12,780

$48K

1.16M

NASDAQ APLS Apellis Pharmaceuticals

Deschatelets Pascal / officer: Chief Scientific Officer

05/21/2025

Sell

$3.76

12,780

$48K